Excelsior Medical Co., Ltd. (TPE:4104)

Excelsior Medical Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	8,983	8,789	8,539	8,233	7,187	6,573
Revenue Growth	3.90%	2.94%	3.71%	14.56%	9.34%	-1.53%
Gross Profit Gross Profit Growth	1,918	1,874	1,781	1,670	1,514	1,374
Operating Income Operating Income Growth	726.75	727.54	753.32	702.88	606.61	595.03
Net Income Net Income Growth	815.8	805.86	771.26	746.61	667.45	607.15
Earnings Per Share EPS Growth	4.61	4.68	4.48	4.33	3.87	3.52
EPS Growth	0.39%	4.46%	3.38%	11.88%	10.16%	5.78%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Adjustment and Elimination Adjustment and Elimination Growth	-252.88	-208.21	-169.37	-141.21	-82.81	-97.47
Other Department Other Department Growth	733.35	634.26	546.46	394.17	305.51	323.59
Yaoya Segment Yaoya Segment Growth	1,378	1,387	1,573	1,594	1,292	1,028
Arich Enterprise Department Arich Enterprise Department Growth	1,565	1,547	1,298	1,140	1,018	945.66
Excelsior Medical Department Excelsior Medical Department Growth	5,560	5,429	5,291	5,247	4,654	4,373
Total Total Growth	8,983	8,789	8,539	8,233	7,187	6,573

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	3,816	3,534	5,048	3,406	3,229	3,772
Total Debt Total Debt Growth	1,202	2,154	1,426	1,442	808.58	761.99
Net Cash (Debt) Net Cash Growth	2,614	1,381	3,622	1,964	2,420	3,010
Net Cash Growth	27.98%	-61.88%	84.42%	-18.85%	-19.59%	5.90%
Net Cash Per Share Net Cash Per Share Growth	14.75	8.01	21.03	11.40	14.04	17.45

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	310.79	-1,364	2,471	107.1	637.13	945.05
Capital Expenditures CapEx Growth	-81.41	-77.79	-114.87	-126.37	-171.6	-164.69
Free Cash Flow Free Cash Flow Growth	229.37	-1,441	2,357	-19.27	465.53	780.36
Free Cash Flow Growth	28.86%	-	-	-	-40.34%	-6.96%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	21.35%	21.33%	20.86%	20.28%	21.07%	20.90%
Operating Margin	8.09%	8.28%	8.82%	8.54%	8.44%	9.05%
Pretax Margin	13.12%	13.45%	13.75%	13.90%	13.41%	13.29%
Profit Margin	9.08%	9.17%	9.03%	9.07%	9.29%	9.24%
FCF Margin	2.55%	-16.40%	27.60%	-0.23%	6.48%	11.87%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	4.300	4.300	3.800	3.447	3.153	2.879
Dividend Per Share Growth	18.82%	13.16%	10.25%	9.31%	9.50%	-0.00%
Dividend Yield	6.15%	5.67%	5.22%	5.04%	6.56%	7.80%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	15.27	17.37	18.22	18.43	15.01	13.39
Forward PE	-	17.03	17.81	15.71	15.71	11.84
P/FCF Ratio	57.81	-	5.96	-	21.52	10.42
PS Ratio	1.48	1.59	1.65	1.67	1.39	1.24

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error